跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
米托坦片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Mitotane Tablets
Approved
化学药品
Mitotane Tablets
HRA Pharma Rare Diseases SAS
🇨🇳 National Medical Products Administration
Approval Date
Sep 5, 2023
Approval ID
8TELhnuzUKK
Company
HRA Pharma Rare Diseases SAS
Type
化学药品
Approval Details
Approval Id
8TELhnuzUKK
Approval Number
国药准字HJ20230105
Generic Name
米托坦片
Generic Name En
Mitotane Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
0.5g
Reg Date
2023-09-05
Expired Date
2028-09-04
Company Name
HRA Pharma Rare Diseases SAS
Production Company Name
LATINA PHARMA SPA
Company Detail Path
/organization/hra-pharma-rare-diseases-sas
Production Company Detail Path
/organization/latina-pharma-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 5, 2023
Approval ID
8TELhnuzUKK
Type
化学药品
Back to NMPA Approvals